Veritex (VBTX) Insider Sale: Director Reduces Holdings to 50,652 Shares

Rhea-AI Filing Summary

Veritex Holdings director John Sughrue reported a sale of 5,669 shares of Veritex common stock on 08/15/2025 at a price of $32 per share. Following the transaction he directly owned 50,652 shares and had indirect beneficial ownership of 760 shares via his son. The Form 4 was signed by C. Malcolm Holland, III on 08/19/2025.

Positive

• Transparent disclosure of insider sale and remaining holdings, including indirect ownership via family member
• Continued significant insider ownership post-sale (50,652 shares direct) which can align management and shareholder interests

Negative

• Insider sale reduced direct holdings by 5,669 shares
• No indication of a 10b5-1 plan disclosed in the form to explain timing of the sale

Insights

Financial Analyst

TL;DR: A routine insider sale by a director reduced direct holdings modestly without changing control.

The reported sale of 5,669 shares at $32 is a routine disclosure showing a director liquidity event. Post-transaction direct ownership of 50,652 shares still represents meaningful insider ownership, while 760 shares are held indirectly. There are no derivative transactions or other compensatory grants reported. From a market-impact perspective this type of single-line sale is typically immaterial to company valuation absent additional context.

Corporate Governance Expert

TL;DR: Disclosure complies with Section 16 reporting; transaction appears ordinary and properly reported.

The Form 4 discloses a direct sale and reports indirect holdings via a family member, which aligns with standard disclosure practices. The filing identifies the reporting person as a director and includes signature and dates. There is no indication of a Rule 10b5-1 plan or related amendments. Governance-wise, the record shows transparency but no material governance event.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sughrue John

(Last) (First) (Middle)

C/O VERITEX HOLDINGS, INC.

8214 WESTCHESTER DRIVE, SUITE 800

(Street)

DALLAS TX 75225

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Veritex Holdings, Inc. [ VBTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		S		5,669	D	$32	50,652	D
Common Stock								760	I	By Son

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ C. Malcolm Holland, III	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Veritex director John Sughrue report on Form 4 (VBTX)?

He reported a sale of 5,669 shares on 08/15/2025 at $32 per share and retained 50,652 shares directly.

How much indirect ownership does the reporting person have in VBTX?

The filing shows indirect beneficial ownership of 760 shares held by his son.

Does the Form 4 show any option exercises or derivative transactions for VBTX?

No. Table II contains no derivative transactions; only a non-derivative sale is reported.

When was the Form 4 signed and filed?

The signature block shows the form was signed by C. Malcolm Holland, III on 08/19/2025.

Is there any amendment or 10b5-1 plan noted on the filing?

The form does not indicate an amendment date or that the transaction was made pursuant to a Rule 10b5-1 plan.